Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sacubitril/Allisartan vs Amlodipine for Hypertension in Overweight/Obese Patients
NCT07241338Phase 4Not yet recruiting
- Start
- Nov 2025
- Primary completion
- Nov 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of Xinchaotuo in hypertension (HTN). Planned start Nov 2025; status: not yet recruiting.
02
Drugs
Xinchaotuo
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT07241338.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07241338.